The Oral α4β7 Integrin Specific Antagonist PN-10943 is More Effective than PTG-100 in Multiple Preclinical Studies

Larry Mattheakis, PhD, 50th Anniversary of Digestive Disease Week, May 18-21, 2019, San Diego, California, United States.